INVICTA — Invicta Diagnostic Share Price
Last trade - 00:00- IN₹1.09bn
- IN₹1.12bn
- IN₹83.67m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 11.15 | ||
| Price to Tang. Book | 11.15 | ||
| Price to Free Cashflow | 215.78 | ||
| Price to Sales | 12.97 | ||
| EV to EBITDA | 29.03 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 21.29% | ||
| Return on Equity | 21.01% | ||
| Operating Margin | 34.47% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | n/a | n/a | n/a | n/a | 83.67 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Invicta Diagnostic Limited is engaged in the diagnostic chain offering comprehensive radiology and pathology solutions. It offers a one-stop solution for pathology and radiology testing services such as imaging (including radiology), pathology/clinical laboratory and tele-radiology to customers under the brand name PC Diagnostics through its operational network, which consists of eight diagnostic centers and one centralized laboratory across Mumbai Metropolitan Region in the state of Maharashtra. Its test menu includes pathology tests ranging from basic biochemistry and clinical pathology which are performed at its own centers to cytogenetics and high-end molecular diagnostic tests which are outsourced to larger reference laboratories, and radiology tests ranging from basic echocardiograms, X-rays and ultrasounds to advanced radiology tests including computerized tomography (CT) scans, magnetic resonance imaging (MRI) scans and advanced positron emission tomography CT.
Directors
- Last Annual
- March 31st, 2024
- Last Interim
- January 1st, 1970
- Incorporated
- December 1st, 2023
- Public Since
- December 8th, 2025
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 12,571,973
- Address
- MUMBAI, 400060
- Web
- https://www.pcdiagnostics.in
- Phone
- +91 2249710036
- Auditors
- Piyush Kothari & Associates
Similar to INVICTA
Aatmaj Healthcare
National Stock Exchange of India
Apollo Hospitals Enterprise
National Stock Exchange of India
Artemis Medicare Services
National Stock Exchange of India
Aster DM Healthcare
National Stock Exchange of India
Chandan Healthcare
National Stock Exchange of India
FAQ
As of Today at 20:22 UTC, shares in Invicta Diagnostic are trading at IN₹86.35. This share price information is delayed by 15 minutes.
Shares in Invicta Diagnostic last closed at IN₹86.35 and the price had moved by over the past 365 days. In terms of relative price strength the Invicta Diagnostic share price has matched the S&P BSE 100 Index by over the past year.
There is no consensus recommendation for this security.
Find out moreInvicta Diagnostic does not currently pay a dividend.
Invicta Diagnostic does not currently pay a dividend.
Invicta Diagnostic does not currently pay a dividend.
To buy shares in Invicta Diagnostic you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹86.35, shares in Invicta Diagnostic had a market capitalisation of IN₹1.09bn.
Here are the trading details for Invicta Diagnostic:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: INVICTA
Based on an overall assessment of its quality, value and momentum Invicta Diagnostic is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Invicta Diagnostic. Over the past six months, its share price has matched the S&P BSE 100 Index by .
As of the last closing price of IN₹86.35, shares in Invicta Diagnostic were trading -6.07% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Invicta Diagnostic PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹86.35.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Invicta Diagnostic's directors